Karoline Spaepen

3.1k total citations · 1 hit paper
19 papers, 2.3k citations indexed

About

Karoline Spaepen is a scholar working on Pathology and Forensic Medicine, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Karoline Spaepen has authored 19 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pathology and Forensic Medicine, 15 papers in Radiology, Nuclear Medicine and Imaging and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Karoline Spaepen's work include Medical Imaging Techniques and Applications (15 papers), Lymphoma Diagnosis and Treatment (14 papers) and Lung Cancer Treatments and Mutations (8 papers). Karoline Spaepen is often cited by papers focused on Medical Imaging Techniques and Applications (15 papers), Lymphoma Diagnosis and Treatment (14 papers) and Lung Cancer Treatments and Mutations (8 papers). Karoline Spaepen collaborates with scholars based in Belgium, India and United States. Karoline Spaepen's co-authors include Sigrid Stroobants, Peter Vandenberghe, Patrick Dupont, Gregor Verhoef, José Thomas, Jan Balzarini, Christine De Wolf‐Peeters, Guy Bormans, Luc Mortelmans and Bruce D. Cheson and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Oncology.

In The Last Decade

Karoline Spaepen

19 papers receiving 2.3k citations

Hit Papers

Use of Positron Emission Tomography for Response Assessme... 2007 2026 2013 2019 2007 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karoline Spaepen Belgium 11 1.7k 1.3k 838 713 448 19 2.3k
Alberto Biggi Italy 18 2.2k 1.3× 1.4k 1.0× 1.0k 1.2× 936 1.3× 633 1.4× 42 2.9k
A.R. Timothy United Kingdom 16 807 0.5× 621 0.5× 521 0.6× 348 0.5× 251 0.6× 29 1.4k
T. Girinsky France 28 1.3k 0.8× 837 0.6× 925 1.1× 491 0.7× 774 1.7× 87 2.9k
Markus Bangerter Germany 17 914 0.5× 750 0.6× 492 0.6× 243 0.3× 242 0.5× 39 1.8k
Monica Tani Italy 26 1.7k 1.0× 459 0.3× 385 0.5× 509 0.7× 819 1.8× 105 2.2k
Caterina Patti Italy 19 1.4k 0.8× 501 0.4× 358 0.4× 458 0.6× 608 1.4× 75 1.7k
James F. Caravelli United States 24 531 0.3× 480 0.4× 1.1k 1.3× 197 0.3× 758 1.7× 38 2.0k
Stéphane Bardet France 33 724 0.4× 1.3k 1.0× 624 0.7× 312 0.4× 478 1.1× 90 3.3k
S N Reske Germany 10 526 0.3× 699 0.5× 584 0.7× 173 0.2× 208 0.5× 21 1.2k
Giovanni Serio Italy 15 1.4k 0.8× 286 0.2× 504 0.6× 451 0.6× 1.3k 2.9× 41 2.4k

Countries citing papers authored by Karoline Spaepen

Since Specialization
Citations

This map shows the geographic impact of Karoline Spaepen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karoline Spaepen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karoline Spaepen more than expected).

Fields of papers citing papers by Karoline Spaepen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karoline Spaepen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karoline Spaepen. The network helps show where Karoline Spaepen may publish in the future.

Co-authorship network of co-authors of Karoline Spaepen

This figure shows the co-authorship network connecting the top 25 collaborators of Karoline Spaepen. A scholar is included among the top collaborators of Karoline Spaepen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karoline Spaepen. Karoline Spaepen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Janssens, Jozef, et al.. (2013). Ultra-late recurrences of gastro-intestinal carcinoma after primary resection: the mechanism of dormancy.. PubMed. 76(2). 251–4. 1 indexed citations
2.
Spaepen, Karoline, et al.. (2008). Non-Hodgkin lymphoma: retrospective study on the cost-effectiveness of early treatment response assessment by FDG-PET. European Journal of Nuclear Medicine and Molecular Imaging. 35(6). 1074–1080. 8 indexed citations
3.
Juweid, Malik E., Sigrid Stroobants, Otto S. Hoekstra, et al.. (2007). Use of Positron Emission Tomography for Response Assessment of Lymphoma: Consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma. Journal of Clinical Oncology. 25(5). 571–578. 967 indexed citations breakdown →
4.
Brepoels, Lieselot, Sigrid Stroobants, Walter De Wever, et al.. (2007). Hodgkin's lymphoma: Response assessment by revised international workshop criteria. European Journal of Nuclear Medicine and Molecular Imaging. 34. 1 indexed citations
5.
Brepoels, Lieselot, Sigrid Stroobants, Walter De Wever, et al.. (2007). Aggressive and indolent non-Hodgkin's lymphoma: Response assessment by Integrated International Workshop Criteria. Leukemia & lymphoma. 48(8). 1522–1530. 29 indexed citations
6.
Brepoels, Lieselot, Sigrid Stroobants, Walter De Wever, et al.. (2007). Hodgkin lymphoma: Response assessment by Revised International Workshop Criteria. Leukemia & lymphoma. 48(8). 1539–1547. 47 indexed citations
7.
Brepoels, Lieselot, Sigrid Stroobants, Peter Vandenberghe, et al.. (2007). Effect of corticosteroids on 18F-FDG uptake in tumor lesions after chemotherapy.. PubMed. 48(3). 390–7. 25 indexed citations
8.
Belhocine, Tarik, Karoline Spaepen, Cathérine Castaigne, et al.. (2006). 18FDG PET in oncology: The best and the worst (Review). International Journal of Oncology. 28(5). 1249–61. 50 indexed citations
9.
Spaepen, Karoline, Sigrid Stroobants, Patrick Dupont, et al.. (2003). [18F]FDG PET monitoring of tumour response to chemotherapy: does [18F]FDG uptake correlate with the viable tumour cell fraction?. European Journal of Nuclear Medicine and Molecular Imaging. 30(5). 682–688. 150 indexed citations
11.
Spaepen, Karoline, Sigrid Stroobants, Patrick Dupont, et al.. (2003). Prognostic value of pretransplant positron emission tomography using fluorine-18 fluorodeoxyglucose in patients with aggressive lymphoma treated with high-dose chemotherapy and stem cell transplantation. 44(5). 4 indexed citations
12.
Spaepen, Karoline, Sigrid Stroobants, Gregor Verhoef, & Luc Mortelmans. (2003). Positron emission tomography with [18F]FDG for therapy response monitoring in lymphoma patients. European Journal of Nuclear Medicine and Molecular Imaging. 30(S1). S97–S105. 57 indexed citations
13.
Spaepen, Karoline, Sigrid Stroobants, Patrick Dupont, et al.. (2002). Early restaging positron emission tomography with 18F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin’s lymphoma. Annals of Oncology. 13(9). 1356–1363. 317 indexed citations
14.
Spaepen, Karoline, Sigrid Stroobants, Patrick Dupont, et al.. (2001). Early restaging positron emmision tomography (PET) with 18F-fluorodeoxyglucose ((18)FDG) predicts outcome in patients with aggressive non Hodgkin's lymphoma (NHL).. Blood. 98(11). 3 indexed citations
16.
Stroobants, Sigrid, J. Goeminne, Marc Martens, et al.. (2001). Early evaluation of tumour response to STI 571 with FDG-PET in patients with soft tissue sarcomas (STS). European Journal of Cancer. 37. S33–S34. 1 indexed citations
18.
Spaepen, Karoline & Luc Mortelmans. (2001). Evaluation of treatment response in patients with lymphoma using [18F]FDG-PET: differences between non-Hodgkin's lymphoma and Hodgkin's disease.. PubMed. 45(3). 269–73. 8 indexed citations
19.
Spaepen, Karoline, Sigrid Stroobants, Patrick Dupont, et al.. (2000). Positron emission tomography with fluorodeoxyglucose after first line chemotherapy in Non Hodgkin's Lymphoma. 41(5). 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026